An evaluation of the permanence of the "tardive dyskinesias".
D000328:Adult; D000368:Aged; D001264:Athetosis / Q000139:chemically induced; D001925:Brain Damage, Chronic / Q000188:drug therapy; D002819:Chorea / Q000139:chemically induced; D003863:Depression / Q000188:drug therapy; D004569:Electroencephalography; D004827:Epilepsy / Q000188:drug therapy; D005260:Female; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009040:Motion Pictures; D009069:Movement Disorders / Q000139:chemically induced*; D019965:Neurocognitive Disorders / Q000188:drug therapy; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D010640:Phenothiazines / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy; D013997:Time Factors
D010640:Phenothiazines